Sera investment share price

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd. BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.

P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes. Shares Outstanding Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public. Public Float The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. Dividend Yield A company's dividend expressed as a percentage of its current stock price. Key Stock Data • Shares Sold Short The total number of shares of a security that have been sold short and not yet repurchased. Change from Last Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month. P...

• Home • Budget 2022 • Market • CaFE Invest • Commodities • IPO NEWS • IPOs • Economy • Tech • Auto • SME • Mobility • Industry • Banking & Finance • Technology • SME/Start-ups • Audio • Jobs • Education • Mutual Funds • Sports • Money • Insurance • Income Tax • Infrastructure • Railways • Aviation • Roadways • India • Lifestyle • Travel & Tourism • Health • Science • From The Print • International • Edits & Columns • Opinion • FE 360 • Politics • Economy • Personal Finance Print • Front Page • FE Insight • Fe@Campus • Brand Wagon • Todays Paper • ePaper • Photos • Videos • Infographics • Horoscope • archive • Digital Currency Sera Investments & Finance India Ltd. is a Public Limited Listed company incorporated on 11/09/1985 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900GJ1985PLC110976 and registration number is 037452. Currently company belongs to the Industry of Finance & Investments. Company’s Total Operating Revenue is Rs. 3.05 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2022.

Quotes 5-day view Delayed Nasdaq 06/12/2023 06/13/2023 06/14/2023 06/15/2023 06/16/2023 Date 3.47(c) 3.43(c) 3.31(c) 3.42(c) 3.6679 Last 123 018 39 289 16 552 36 178 45 649 Volume +13.03% -1.15% -3.50% +3.32% +7.25% Change More quotes Estimated financial data (e) (USD) Sales 2023 0,83M - - Net income 2023 -43,9M - - Net Debt 2023 - - - P/E ratio 2023 -2,43x Yield 2023 - Sales 2024 7,73M - - Net income 2024 -43,6M - - Net Debt 2024 - - - P/E ratio 2024 -2,46x Yield 2024 - Capitalization 106M 106M - Capi. / Sales 2023 128x Capi. / Sales 2024 13,7x Nbr of Employees 88 Free-Float 81,2% More Financials Company Sera Prognostics, Inc. is a women's health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop, and commercialize clinically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found...

P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes. Shares Outstanding Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public. Public Float The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. Dividend Yield A company's dividend expressed as a percentage of its current stock price. Key Stock Data • Shares Sold Short The total number of shares of a security that have been sold short and not yet repurchased. Change from Last Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month. P...

Quotes 5-day view Delayed Nasdaq 06/12/2023 06/13/2023 06/14/2023 06/15/2023 06/16/2023 Date 3.47(c) 3.43(c) 3.31(c) 3.42(c) 3.57 Last 123 018 39 289 16 552 36 178 92 801 Volume +13.03% -1.15% -3.50% +3.32% +4.39% Change More quotes Estimated financial data (e) (USD) Sales 2023 0,83M - - Net income 2023 -43,9M - - Net Debt 2023 - - - P/E ratio 2023 -2,43x Yield 2023 - Sales 2024 7,73M - - Net income 2024 -43,6M - - Net Debt 2024 - - - P/E ratio 2024 -2,46x Yield 2024 - Capitalization 106M 106M - Capi. / Sales 2023 128x Capi. / Sales 2024 13,7x Nbr of Employees 88 Free-Float 81,2% More Financials Company Sera Prognostics, Inc. is a women's health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop, and commercialize clinically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd. BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time). By using this site, you agree to the Terms of Service and Privacy Policy.

• Home • Budget 2022 • Market • CaFE Invest • Commodities • IPO NEWS • IPOs • Economy • Tech • Auto • SME • Mobility • Industry • Banking & Finance • Technology • SME/Start-ups • Audio • Jobs • Education • Mutual Funds • Sports • Money • Insurance • Income Tax • Infrastructure • Railways • Aviation • Roadways • India • Lifestyle • Travel & Tourism • Health • Science • From The Print • International • Edits & Columns • Opinion • FE 360 • Politics • Economy • Personal Finance Print • Front Page • FE Insight • Fe@Campus • Brand Wagon • Todays Paper • ePaper • Photos • Videos • Infographics • Horoscope • archive • Digital Currency Sera Investments & Finance India Ltd. is a Public Limited Listed company incorporated on 11/09/1985 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900GJ1985PLC110976 and registration number is 037452. Currently company belongs to the Industry of Finance & Investments. Company’s Total Operating Revenue is Rs. 3.05 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2022.

Quotes 5-day view Delayed Nasdaq 06/12/2023 06/13/2023 06/14/2023 06/15/2023 06/16/2023 Date 3.47(c) 3.43(c) 3.31(c) 3.42(c) 3.57 Last 123 018 39 289 16 552 36 178 92 801 Volume +13.03% -1.15% -3.50% +3.32% +4.39% Change More quotes Estimated financial data (e) (USD) Sales 2023 0,83M - - Net income 2023 -43,9M - - Net Debt 2023 - - - P/E ratio 2023 -2,43x Yield 2023 - Sales 2024 7,73M - - Net income 2024 -43,6M - - Net Debt 2024 - - - P/E ratio 2024 -2,46x Yield 2024 - Capitalization 106M 106M - Capi. / Sales 2023 128x Capi. / Sales 2024 13,7x Nbr of Employees 88 Free-Float 81,2% More Financials Company Sera Prognostics, Inc. is a women's health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop, and commercialize clinically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found...

• Markets • Stocks • Funds • ETFs • Bonds • Investing Ideas • Best Investments • Christine Benz’s Portfolios • Best Companies to Own • Best ETFs • Guide to 529 Plans • Asset Management Companies • Topics • Portfolio Construction • Economy • Sustainable Investing • Personal Finance • Retirement • Save for College • Start Investing • For Advisors • Alternative Investments • Media • Podcasts • Free Email Newsletters • Morningstar Magazine • Videos • Investing Definitions • Just For Investors • Morningstar Investor • Morningstar Investor Newsletters • Legacy Portfolio Manager Morningstar Quantitative ratings for equities (denoted on this page by ) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Does SERA pay dividends? If so, how much? No. SERA does not currently have a forward dividend yield. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. Learn more about How big is Sera Prognostics Inc Class A? SERA’s ma...